Indena Cannabidiol Cbd Indena’s journey in cbd production began in 2021 with two key authorizations: permission from the italian ministry of health to manufacture cannabinoid based cannabis extracts, and aifa’s approval for pharmaceutical grade cbd. Indena has received the european pharmacopoeia certificate of eligibility (cep) for its cannabidiol (cbd) extract, making it the first global api manufacturer to achieve this certification.
Indena Cannabidiol Cbd Indena, a leading italian natural products supplier to international markets, is the first company authorized by the italian ministry of health and italian medicines agency (aifa) to produce cannabinoid based cannabis extracts. The approval process continued and indena has also received authorisation from the aifa, making it one of the few companies in the world able to produce cannabidiol (cbd) for the pharmaceutical market. cbd is an active ingredient obtained by extraction and isolation from the inflorescences and aerial parts of hemp (cannabis sativa l). Indena will produce pharmaceutical grade cannabidiol (cbd) for the global market for clinical and commercial use. indena is the first company in italy to receive authorisation from the ministry of health to manufacture cannabinoid based cannabis extracts. Indena will produce pharmaceutical grade cannabidiol (cbd) for the global market for both clinical and commercial use. the raw material, consisting of registered varieties of hemp with a thc level of less than 0.2%, will be grown and processed in italy.
Indena Cannabidiol Cbd Indena will produce pharmaceutical grade cannabidiol (cbd) for the global market for clinical and commercial use. indena is the first company in italy to receive authorisation from the ministry of health to manufacture cannabinoid based cannabis extracts. Indena will produce pharmaceutical grade cannabidiol (cbd) for the global market for both clinical and commercial use. the raw material, consisting of registered varieties of hemp with a thc level of less than 0.2%, will be grown and processed in italy. Indena's ep authorisation follows two previous approvals in 2021 — with the italian ministry of health granting indena permission to manufacture cannabinoid based cannabis extracts, as well as the aifa authorising the production of cbd for pharmaceutical use. The approval process continued, and indena also received gmp authorization from aifa (italian pharmaceutical regulatory body), making it one of the few companies in the world able to produce cannabidiol (cbd) for the pharmaceutical market. Indena achieves another milestone: it is the first global api manufacturer with european certificate of eligibility certification for its cbd extract, which the company produces for clinical and commercial use. Indena will produce pharmaceutical grade cannabidiol (cbd) for the global market for clinical and commercial use. it is reportedly the first company in italy to receive authorization from the ministry of health to manufacture cannabinoid based cannabis extracts.
Indena Cannabidiol Cbd Indena's ep authorisation follows two previous approvals in 2021 — with the italian ministry of health granting indena permission to manufacture cannabinoid based cannabis extracts, as well as the aifa authorising the production of cbd for pharmaceutical use. The approval process continued, and indena also received gmp authorization from aifa (italian pharmaceutical regulatory body), making it one of the few companies in the world able to produce cannabidiol (cbd) for the pharmaceutical market. Indena achieves another milestone: it is the first global api manufacturer with european certificate of eligibility certification for its cbd extract, which the company produces for clinical and commercial use. Indena will produce pharmaceutical grade cannabidiol (cbd) for the global market for clinical and commercial use. it is reportedly the first company in italy to receive authorization from the ministry of health to manufacture cannabinoid based cannabis extracts.
Indena Science Is Our Nature Indena achieves another milestone: it is the first global api manufacturer with european certificate of eligibility certification for its cbd extract, which the company produces for clinical and commercial use. Indena will produce pharmaceutical grade cannabidiol (cbd) for the global market for clinical and commercial use. it is reportedly the first company in italy to receive authorization from the ministry of health to manufacture cannabinoid based cannabis extracts.
Indena Science Is Our Nature
Comments are closed.